[FOR RELEASE November 3, 2015 China Biologic Reports Financial Results for the Third Quarter of 2015 3Q15 Total Sales Up 14.4% YoY to $78.8 Million 3Q15 Non-GAAP Net Income Up 23.6% YoY to $26.2 Million 9M15 Total Sales Up 23.2% YoY to $228.2 Million 9M15 Non-GAAP Net Income Up 31.1% YoY to $79.7 Million Raises Forecast for FY15 Non-GAAP Adjusted] []
[FOR RELEASE November 3, 2015 China Biologic Reports Financial Results for the Third Quarter of 2015 3Q15 Total Sales Up 14.4% YoY to $78.8 Million 3Q15 Non-GAAP Net Income Up 23.6% YoY to $26.2 Million 9M15 Total Sales Up 23.2% YoY to $228.2 Million 9M15 Non-GAAP Net Income Up 31.1% YoY to $79.7 Million Raises Forecast for FY15 Non-GAAP Adjusted] []
[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Ming Yang Chief Financial Officer (Principal Financial Officer)]
[1 Announcement dated November 2, 2015 for the completion of Major Transaction in relation to the Disposal of Telecommunications Towers and Related Assets. ]
[1 Announcement dated November 2, 2015 for the completion of Major Transaction in relation to the Disposal of Telecommunications Towers and Related Assets. ]
[Convertible note sale agreement Purchaser Golden Meditech Holdings Limited ( Vendor Excellent China Healthcare Investment Limited ( MinterEllison LAWYERS LEVEL 25, ONE PACIFIC PLACE, 88 QUEENSWAY, HONG KONG TEL: +852 2841 6888 FAX: +852 2810 0235 www.minterellison.com Convertible note sale agreement Details 4 Agreed terms 5 1.] []
[Number Page 1.1 Announcement, dated November 2, 2015 A-1]
[Convertible note sale agreement Purchaser Golden Meditech Holdings Limited ( Vendor Excellent China Healthcare Investment Limited ( MinterEllison LAWYERS LEVEL 25, ONE PACIFIC PLACE, 88 QUEENSWAY, HONG KONG TEL: +852 2841 6888 FAX: +852 2810 0235 www.minterellison.com Convertible note sale agreement Details 4 Agreed terms 5 1.] []
